CE vs REPL
Celanese Corporation (CE) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
REPL does not have a complete income-statement cache yet.
CE currently screens at market cap $5.92B. REPL currently screens at market cap $825.7M.
Not investment advice. Open the CE and REPL stock pages for the full models.
Not investment advice.